Zai Lab Operating Margin 2016-2022 | ZLAB
Current and historical operating margin for Zai Lab (ZLAB) over the last 10 years. The current operating profit margin for Zai Lab as of March 31, 2022 is -324.08%.
| Zai Lab Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2022-03-31 |
$0.17B |
$-0.55B |
-323.39% |
| 2021-12-31 |
$0.14B |
$-0.70B |
-486.11% |
| 2021-09-30 |
$0.12B |
$-0.58B |
-500.87% |
| 2021-06-30 |
$0.09B |
$-0.57B |
-654.02% |
| 2020-12-31 |
$0.04B |
$-0.22B |
-571.05% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.927B |
$0.144B |
|
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
|
